跳至主要内容
临床试验/RPCEC00000289
RPCEC00000289尚未招募3 期

Comparative study of the efficacy and safety of topic OLEOZON, Ketoconazole and Terbinafine in patients with epidermophytosis.

ational Center For Scientific Research0 个研究点目标入组 300 人开始时间: 2018年9月28日最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled trial. Masking: Open. Control group: Active. Assignment: Parallel. Purpose: Treatment

入排标准

年龄范围
18 years 至 80 years(—)
性别
All

入选标准

  • Patients greater than or equal to 18 years, of both sexes, who have signed their informed consent to participate in the study, with clinical diagnosis and positive mycological diagnosis of tinea pedis variety squamous, in addition patients without other infection added, virgin of treatments or with more than five days without treatment Specific topical or systemic.

排除标准

  • Decompensated diabetes mellitus (fasting glucose> 7 mmol/L), diagnosed neoplasms, severe septic states, history of liver failure, history of renal failure, chronic diseases, pregnancy, concomitant use of corticosteroids, cytostatics or immunosuppressants and antibiotics, clinical history usual allergy to medications or any other special condition that at the discretion of the doctor puts your health and life at risk during the study.

研究者

发起方
ational Center For Scientific Research

相似试验